6505--Carbidopa/Levodopa SA Tablet
ID: 36E79725R0008Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/99fd2706b5bf47cdbf7ab1a2002c03a7/view
Timeline
    Description

    The Department of Veterans Affairs is seeking pharmaceutical suppliers to establish a national contract for the provision of Carbidopa/Levodopa SA tablets through its Pharmaceutical Prime Vendor program. The Request for Proposal (RFP) outlines specific requirements for potential contractors, including pricing structures for the base year and four option years, compliance with the Drug Supply Chain Security Act, and the necessity for Good Manufacturing Practices (cGMP) status. This procurement is crucial for ensuring a reliable supply of essential medications for veteran and military healthcare systems across the nation. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details regarding the proposal submission process and deadlines.

    Point(s) of Contact
    Christopher CarthronContract Specialist
    Christopher.Carthron@va.gov
    Files
    Title
    Posted
    36E79725R0008_1.docx
    The Department of Veterans Affairs (VA) plans to issue Request for Proposal (RFP) 36E79725R0008 for Carbidopa/Levodopa sustained release (SA) tablets, indicating an unrestricted procurement to supply various federal health services, including the Department of Defense and the Bureau of Prisons. The awarded contract will ensure a continuous supply of these medications for one year, with the possibility of extending for four additional yearly periods. Offerors must provide unique branding and packaging without overlapping labels. The electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026. Estimated annual usage totals approximately 119,875 bottles split between two dosage forms. All details and updates regarding the proposal will be available exclusively on sam.gov, with no paper copies distributed. Interested parties are encouraged to direct questions to the designated contracting officer, Chris Carthron.
    36E79725R0008.docx
    The document outlines a Request for Proposal (RFP) from the Department of Veterans Affairs (VA) for pharmaceutical suppliers. The purpose is to establish a national contract for the provision of specific drug products, namely Carbidopa/Levodopa tablets, through its Pharmaceutical Prime Vendor (PPV) program. The RFP stipulates requirements for potential contractors, including pricing structures for the base year and four option years, product registration details, specific drug codes (NDCs), and compliance with the Drug Supply Chain Security Act (DSCSA). Additionally, the document emphasizes that contractors must have an acceptable Good Manufacturing Practices (cGMP) status and maintain manufacturer consistency throughout the contract period. Key details include the necessity for a Letter of Commitment from manufacturers or distributors, requirements for invoicing, quarterly sales reporting, and documenting contract compliance. The implementation period and delivery expectations are clearly defined, along with procedures for handling recalls and nonconformance issues. By outlining these parameters, the RFP reflects the VA’s commitment to ensuring a reliable drug supply at negotiated prices for veteran and military healthcare systems nationwide.
    Lifecycle
    Title
    Type
    6505--Carbidopa/Levodopa SA Tablet
    Currently viewing
    Solicitation
    6505--Carbidopa/Levodopa SA Tablet
    Presolicitation
    Similar Opportunities
    6505--Baclofen Tablets (VA-25-00026620)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Baclofen Tablets under the solicitation titled "6505--Baclofen Tablets (VA-25-00026620)." The primary objective of this procurement is to establish a reliable source for various strengths of Baclofen tablets, ensuring consistent availability and quality at pre-negotiated prices, while complying with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is crucial for maintaining the pharmaceutical needs of VA facilities, addressing issues such as compliance, backorders, and recalls. Interested offerors must submit their proposals by February 5, 2025, at 2:30 PM CST, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to supply Cyclobenzaprine HCL Tablets under solicitation number VA-25-00015093. The procurement involves providing pharmaceutical supplies over a base year and four option years, with specific requirements for submission formats, safety protocols, and compliance with drug supply chain security standards. Cyclobenzaprine is a critical medication used for muscle relaxation, making this procurement essential for ensuring consistent availability for veterans and healthcare facilities. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details regarding the submission process and compliance requirements.
    6505--Nadolol Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Nadolol tablets as part of its Pharmaceutical Prime Vendor Program. This solicitation requires bidders to provide various dosages of Nadolol, along with unique National Drug Codes (NDCs), and to adhere to strict compliance with federal manufacturing practices and regulations, including the Drug Supply Chain Security Act. The consistent supply of these pharmaceuticals is crucial for meeting the healthcare needs of veterans, ensuring they receive necessary medications without interruption. Interested parties should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must adhere to the submission requirements outlined in the solicitation document, which includes a 0.5% cost recovery fee and specific timelines for bid submission.
    6505--Domestic Pharmaceuticals/Med/Surge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a Sources Sought notice to identify qualified domestic pharmaceutical manufacturers capable of supplying a range of medications for the Consolidated Mail Outpatient Pharmacy (CMOP). The procurement aims to ensure a reliable supply of domestically manufactured pharmaceuticals, including glucose test strips, hypertension treatments, and various other essential medications. This initiative is crucial for maintaining the health and well-being of veterans, as it supports ongoing healthcare needs. Interested manufacturers must submit their capability statements by February 5, 2025, to Josie Linaweaver at josie.linaweaver@va.gov, and are reminded to register in the System for Award Management (SAM) prior to contract award.
    6505--Metformin SA Tablets REPACK PROGRAM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Metformin SA Tablets through a repack program, as outlined in solicitation 36E79725R0003. Bidders are required to meet specific packaging standards, including the use of safety-caps that can be converted or deshelled, with bottles having a minimum size of 120cc and a cylindrical design that accommodates a label of specified dimensions. This procurement is critical for ensuring the availability of essential pharmaceutical products for veteran populations, adhering to FDA regulations and maintaining healthcare quality. Interested parties must submit their offers by January 28, 2025, at 2:30 PM CST, and can direct inquiries to Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0117 770-25-2-0182 - National CMOP T0224 TERBINAFINE HCL 1% CREAM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Terbinafine HCL 1% Cream for its Consolidated Mail Outpatient Pharmacy (CMOP) facilities across multiple locations. This acquisition, identified by solicitation number 36C77025Q0117, is set aside for small businesses and requires vendors to provide specific documentation, including a completed price schedule in Excel format and a state wholesale distributor license, to ensure compliance with the Drug Supply Chain Security Act. The timely delivery of these pharmaceuticals is crucial for maintaining a reliable supply for veterans, with a delivery timeframe of 10 days after receipt of order and shipments directed to seven designated CMOP locations. Interested vendors must submit their quotes by January 23, 2025, with an estimated award date of January 28, 2025; for further inquiries, contact Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    Repaglinide
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Repaglinide Tablets. The contract will establish a national supply source for the purchase of Repaglinide 0.5MG, 1MG, and 2MG in 100 count bottles. This acquisition will be unrestricted and fully competitive. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items listed in the schedule will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. Interested parties should contact Phyllis Daraio for any questions/comments. The projected solicitation date is September 2020.
    Valsartan
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used to treat high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The solicitation will be posted on the DLA Bid Board System and beta.SAM.gov, with a projected solicitation date in June 2021. Interested parties should contact Christopher Newman for more information.
    6515--Pharmacy Management System ScriptPro Brand name or Equal
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of a ScriptPro Pharmacy Management System or an equivalent solution, as outlined in the combined synopsis/solicitation RFQ 36C26225Q0148. This procurement aims to enhance pharmacy management capabilities across various Veterans Integrated Service Network (VISN) 22 medical facilities and clinics, ensuring high-quality healthcare service delivery through reliable technological advancements. Interested vendors are encouraged to participate, particularly small businesses, including those owned by veterans and women, with bids due by February 4, 2025, at 7:00 AM PST. For inquiries, potential bidders should contact Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.